CDC42BPB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.433200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.136100E-02
Normal-vs-Stage2
2.306000E-01
Normal-vs-Stage3
8.275400E-01
Normal-vs-Stage4
1.396990E-01
Stage1-vs-Stage2
8.391000E-01
Stage1-vs-Stage3
2.287800E-01
Stage1-vs-Stage4
3.373000E-01
Stage2-vs-Stage3
2.811000E-01
Stage2-vs-Stage4
2.050400E-01
Stage3-vs-Stage4
1.766380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.375800E-01
Normal-vs-AfricanAmerican
4.437000E-01
Normal-vs-Asian
4.225400E-01
Caucasian-vs-AfricanAmerican
8.827400E-01
Caucasian-vs-Asian
7.446200E-01
AfricanAmerican-vs-Asian
9.467600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.202200E-01
Normal-vs-Female
2.782400E-01
Male-vs-Female
4.192400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.188980E-01
Normal-vs-Age(41-60Yrs)
9.813600E-02
Normal-vs-Age(61-80Yrs)
3.434000E-01
Normal-vs-Age(81-100Yrs)
3.676200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.261200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.445400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.387000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.290200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.958360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.030600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.195400E-01
Normal-vs-Daily Drinker
5.183200E-01
Normal-vs-Weekly Drinker
3.115000E-01
Normal-vs-Occasional Drinker
7.691800E-02
Normal-vs-Social Drinker
1.606230E-01
Non Drinker-vs-Daily Drinker
6.790800E-01
Non Drinker-vs-Weekly Drinker
4.660800E-01
Non Drinker-vs-Occasional Drinker
3.042100E-02
Non Drinker-vs-Social Drinker
2.376000E-01
Daily Drinker-vs-Weekly Drinker
3.058000E-01
Daily Drinker-vs-Occasional Drinker
1.540410E-02
Daily Drinker-vs-Social Drinker
1.319640E-01
Weekly Drinker-vs-Occasional Drinker
2.821200E-01
Weekly Drinker-vs-Social Drinker
7.572200E-01
Occasional Drinker-vs-Social Drinker
3.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.342790E-01
Normal-vs-Grade 2
1.214470E-02
Normal-vs-Grade 3
1.405590E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.316200E-01
Grade 1-vs-Grade 3
4.507400E-01
Grade 1-vs-Grade 4
1.342790E-01
Grade 2-vs-Grade 3
3.190400E-01
Grade 2-vs-Grade 4
1.214470E-02
Grade 3-vs-Grade 4
1.405590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.963600E-01
Normal-vs-NonDiabetic
2.325000E-01
Diabetic-vs-NonDiabetic
3.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.011600E-01
Normal-vs-NoPancreatitis
2.707200E-01
Pancreatitis-vs-NoPancreatitis
6.262400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.350400E-01
Normal-vs-N1
2.236400E-01
N0-vs-N1
9.561000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.598400E-02
Normal-vs-TP53-NonMutant
3.918600E-01
TP53-Mutant-vs-TP53-NonMutant
1.506310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
